Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-05-29
2010-12-07
Anderson, James D (Department: 1614)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S298000, C514S183000
Reexamination Certificate
active
07847109
ABSTRACT:
Variously substituted carbonate and carbamate derivatives of triptolide compounds have good aqueous solubility and convert to biologically active compounds in vivo, at a rate which can be modulated by varying the substitution on the prodrug. The prodrugs are useful as immunosuppressive, anti-inflammatory and anticancer agents.
REFERENCES:
patent: 3646201 (1972-02-01), Kallianos et al.
patent: 4005108 (1977-01-01), Kupchan et al.
patent: 5192817 (1993-03-01), Takaishi et al.
patent: 5294443 (1994-03-01), Lipsky et al.
patent: 5430054 (1995-07-01), Qian et al.
patent: 5468772 (1995-11-01), Xu et al.
patent: 5565569 (1996-10-01), Tsujihara et al.
patent: 5580562 (1996-12-01), Lipsky et al.
patent: 5648376 (1997-07-01), Strobel et al.
patent: 5663335 (1997-09-01), Qi et al.
patent: 5759550 (1998-06-01), Wiedmann et al.
patent: 5843452 (1998-12-01), Wiedmann et al.
patent: 5919816 (1999-07-01), Hausheer et al.
patent: 5962516 (1999-10-01), Qi et al.
patent: 5972998 (1999-10-01), Jung et al.
patent: 6004999 (1999-12-01), Jung et al.
patent: 6011042 (2000-01-01), Greenwald et al.
patent: 6150539 (2000-11-01), Musser
patent: 6294546 (2001-09-01), Rosen et al.
patent: 6329148 (2001-12-01), Rosen et al.
patent: 6458537 (2002-10-01), Staub et al.
patent: 6537984 (2003-03-01), Rosen et al.
patent: 6548537 (2003-04-01), Dai et al.
patent: 6569893 (2003-05-01), Dai et al.
patent: 6599499 (2003-07-01), Rosen et al.
patent: 6620843 (2003-09-01), Fidler et al.
patent: 6777441 (2004-08-01), Wang et al.
patent: 6943259 (2005-09-01), Dai et al.
patent: 7019151 (2006-03-01), Dai et al.
patent: 7098348 (2006-08-01), Dai et al.
patent: 7417069 (2008-08-01), Dai et al.
patent: 2002/0077350 (2002-06-01), Babish et al.
patent: 2002/0099051 (2002-07-01), Fidler et al.
patent: 2004/0018260 (2004-01-01), Ren et al.
patent: 2004/0152767 (2004-08-01), Dai et al.
patent: 2004/0198808 (2004-10-01), Dai et al.
patent: 2005/0288645 (2005-12-01), LaVon
patent: 2007/0244080 (2007-10-01), Fidler et al.
patent: 2007/0249048 (2007-10-01), Dai et al.
patent: 2007/0282114 (2007-12-01), An et al.
patent: 2008/0193948 (2008-08-01), Fidler et al.
patent: 2008/0287530 (2008-11-01), Yuan et al.
patent: 1052859 (1991-07-01), None
patent: 1317248 (2001-10-01), None
patent: 0 156 643 (1985-10-01), None
patent: 61-085319 (1986-04-01), None
patent: 03 178977 (1991-08-01), None
patent: WO 94/26265 (1994-11-01), None
patent: WO97/31920 (1997-09-01), None
patent: WO97/31921 (1997-09-01), None
patent: WO98/52933 (1998-11-01), None
patent: WO98/52951 (1998-11-01), None
patent: WO00/12483 (2000-03-01), None
patent: WO 00/63212 (2000-10-01), None
patent: WO 01/15707 (2001-03-01), None
patent: WO 02/056835 (2002-07-01), None
patent: WO 02/070472 (2002-09-01), None
patent: WO 02/074759 (2002-09-01), None
patent: WO 03/101951 (2003-12-01), None
patent: WO 2005/000291 (2005-01-01), None
patent: WO 2005/020887 (2005-01-01), None
patent: WO 2005/062913 (2005-03-01), None
patent: WO 2005/084365 (2005-07-01), None
patent: WO 2006/012204 (2006-02-01), None
patent: WO 2009/023201 (2009-02-01), None
Dan et al.,Tetrahedron Letters, 38(39):6865-6868 (1997).
De Quan Yu et al.,Chinese Chemical Letters, 2(12):937-940 (1991).
Dittert, L.W. et al., “Acetaminophen Prodrugs I Synthesis, Physicochemical Properties, and Analgesic Activity”,Journal of Pharmaceutical Sciences, 57(5):774-780, 1968.
Dittert, L.W. et al., “Acetaminophen Prodrugs II Effect of Structure and Enzyme Source on Enzymatic and Nonenzymatic Hydrolysis of Carbonate Esters,”Journal of Pharmaceutical Sciences, 57(5):780-783, 1968.
de Groot Franciscus M. H. et al., “Synthesis and Biological Evaluation of 2′-Carbamate-Linked and 2′-Carbonate-Linked Prodrugs of Paclitaxel: Selective Activation by the Tumor-Associated Protease Plasmin”,J. Med. Chem.43:3093-3102, 2000.
Anderson, Wayne K. et al., “Synthesis, Evaluation of Chemical Reactivity, and Murine Antineoplastic Activity of 2-Hydroxy-5-(3,4-dichlorophenyl)-6,7- bis(hydroxymethyl)-2,3-dihydro-1H-pyrrolizine Bis(2-propylcarbamate) and 2-Acyloxy Derivatives as Potential Water-Soluble Prodrugs1”,J. Med. Chem.26:1333-1338, 1983.
Kahns Anne M. et al., Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP),Pharmaceutical Research, 10(1):68-74, 1993.
Savolainen, Jouko et al., “Synthesis and in vitrolin vivo evaluation of novel oralN-alkyl- andN,N-dialkyl-carbamate esters of entacapone,”Life Sciences67:205-216, 2000.
Hansen, Laila B. et al., “Ketobemidone prodrugs for buccal delivery”,Acta Pharm. Nord3(2):77-82, 1991.
Weibel, Helle et al., “Macromolecular prodrugs IXX. Kinetics of hydrolysis of benzyl dextran carbonate ester conjugates in aqueous buffer solutions and human plasma”,Acta Pharm. Nord.3(3):159-162, 1991.
Hansen, Kristian T. et al., “Carbamate Ester Prodrus of Dopaminergic Compounds: Synthesis, Stability, and Bioconversion”,Journal of Pharmaceutical Sciences80(8):793-798, 1991.
Tunek, Anders et al., “Hydrolysis of3H-Bambuterol, A Carbamate Prodrug of Terbutaline, in Blood from Humans and Laboratory Animals In Vitro”,Biochemical Pharmacology37(20):3867-3876, 1988.
Huang, Tien L. et al., “Hydrolysis of Carbonates, Thiocarbonates, Carbamates, and Carboxylic Esters of α-Naphthol, β-Naphthol, andp-Nitrophenol by Human, Rat, and Mouse Liver Carboxylesterases”,Pharmaceutical Research10(5):639-648, 1993.
Nassar, Munir N. et al., “Effects of Structural Variations on the Rates of Enzymatic and Nonenzymatic Hydrolysis of Carbonate and Carbamate Esters”,Journal of Pharmaceutical Sciences81(3):295-298, 1992.
Aumuller, G. et al., “Intermediate filaments in sertoli cells”,Microscopy Research and Technique, 20:50-72(1992).
Becker, K. et al., “Thioredoxin reductase as a pathophysiological factor and drug target”,Eur. J. Biochem., 267(20):6118-6125 (2000).
Berg, D. et al., “14-3-3 Proteins in the nervous system”,Nature Reviews Neuroscience,. 4:752-62 (2003).
Britton, R. et al., “New okadaic acid analogues from the marine spongeMerriamum oxeatoand their effect on mitosis”,J. Nat. Prod., 66:838-43 (2003).
Chang, W-T. et al., “Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway”,The Journal of Biological Chemistry, 276(3):2221-2227 (2001).
Chen et al., “Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model”,Transplantation, 73(1):115 (2002).
Chen et al., “Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion”,Transplantation, 70(10):1442-1447 (2000).
Cheng, X.X. et al., Yao Xue Xue Bao,ACTA Pharmaceutica Sinica, 37:339-342 (2002) (English Abstract translation), Only Abstract Considered.
Englebienne et al.,Drug Design Reviews -Online, “The Place of Biosteric Sila Substitution in Drug Design”, 2 pages (2005).
Fidler, J.M. et al., “PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy”,Molecular Cancer Therapeutics, 2(9):855-62 (2003).
Fidler, J.M. et al., “Immunosuppressive activity of the Chinese medicinal plantTripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract”,Transplantation, 74(4):445-457 (2002).
Fruman, D.A. et al., “Phosphoinositide Kinases”,Ann. Rev. Biochem., 67:481-507 (1998).
Fu et al., “14-3-3 Proteins: Structure, Function, and regulation”,Ann. Rev. Pharmacol. Toxicol., 40:617-47 (2000).
Gabbiani, G., “The myofibroblast in wound healing and fibrocontractive diseases”,Journal ofPathology, 200:500-503 (2003).
Garcia, A. et al., “Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis”,Biochimie, 85:721-726 (2003).
Gilles, C. et al., “Tran
Dai Dongcheng
Lennox Edwin S.
Musser John H.
Anderson James D
Dehlinger Peter J.
Finn Meghan
King & Spalding LLP
Myers Fitch Susan J.
LandOfFree
Triptolide derivatives for modulation of apoptosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triptolide derivatives for modulation of apoptosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triptolide derivatives for modulation of apoptosis and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4163662